Last updated on May 2019

AMG 404 in Patients With Advanced Solid Tumors.

Brief description of study

To evaluate the safety and tolerability of AMG 404, a monoclonal antibody that binds to PD-1 and inhibits its engagement with ligands, in patients with advanced solid tumors.

Clinical Study Identifier: NCT03853109

Find a site near you

Start Over

Research Site

Woodville South, Australia
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.